Rotavirus is a leading cause of severe, dehydrating diarrhea in infants and young animals, causing significant global morbidity and mortality. For decades, research was hindered by challenges in establishing reverse genetics systems due to the virus’s complex segmented genome and poor cell culture adaptation. The first helper virus-dependent system (2006) was limited by low efficiency. A 2017 breakthrough established the first fully plasmid-based system, which eliminated helper viruses and revolutionized the field. Subsequent optimizations, such as codon modification and CRISPR/Cas9 integration, have significantly enhanced efficiency, enabling viable systems for diverse human and animal strains. This narrative review summarizes the evolution and technological milestones of rotavirus reverse genetics. We discuss critical applications in analyzing viral gene function, developing novel vaccines, screening antiviral drugs, and investigating cross-species transmission. Finally, we provide an outlook on the future prospects of this transformative technology.
Chen et al. (Sat,) studied this question.